WEB de la revista

Editor in chief

Jean-Michel Kauffmann
Université Libre de Bruxelles
Institut de Pharmacie
Campus de la Plaine, C.P. 205/6
Boulevard du Triumphe, B-1050
Bruxelles, BELGIUM

Instrucciones (resumen tomado de la web)

Papers submitted for publication should be new publications. The submission of a paper is held to imply that it has not previously been published in any language, that is not under consideration for publication elsewhere, and that if accepted for publication it will not be published elsewhere without the written approval of the Editors-in-Chief and consent of the Publisher.

Online Submission of Papers Authors are encouraged to submit their paper online to one for the journal editors by using the Online Submission tool for Talanta. To submit online authors should upload their article as a Microsoft® (MS) Word®, WordPerfect®, LaTeX or PostScript via the journal's Author Gateway homepage at: http://authors.elsevier.com/journal/talanta. The submission tool generates an Adobe Acrobat PDF version of the article which is used for the reviewing process. It is crucial that all graphical and tabular elements be placed within the text, so that the file is suitable for reviewing. Authors, Reviewers and Editors send and receive all correspondence by e-mail and no paper correspondence is necessary. Full instructions how to use the online submission tool are available at the online submission website of the journal.

Mailing of Manuscripts

Authors who prefer to submit their manuscript by post should submit three copies of their paper. Authors are requested to include a note of their fax number and E-mail address when submitting their manuscript. Manuscripts should be presented in double-spaced typescript.

Contributions from North and South America, India, China, Japan, Australia and countries in that half of the world should be sent to:

Professor Gary D. Christian, Department of Chemistry, University of Washington, Box 351700, Seattle WA 98195-1700, USA, Fax number: (206) 685 3478, E-mail: christia@chem.washington.edu

Contributions from Europe, the Middle East and Africa should be sent to:

Professor Jean-Michel Kauffmann, Univeristé Libre de Bruxelles, Institut de Pharmacie, Campus de la Plaine, C.P. 205/6, Boulevard du Triumphe, B-1050 Bruxelles, BELGIUM, Fax number: 32 2 650 5225, E-mail:jmkauf@ulb.ac.be

Refereeing of Papers

All papers submitted are refereed by experts who advise the Editors-in-Chief on the matter of acceptance in accordance with the high standards required and on the understanding that the subject matter has not been previously published and that the authors accept full responsibility for the factual accuracy of the data presented and have obtained any necessary authority to publish. Referees will be encouraged to present critical and unbiased reports which are designed to assist the author in presenting material in the clearest and most unequivocal way possible. At the discretion of the Editors-in-Chief, the names of referees may be disclosed if thereby agreement between author and referee is likely to result. Authors should appreciate that the comments of referees are presented in a constructive spirit, and that agreement between the views of author and referee must result in a higher standard of publication.

Preliminary communications will be refereed urgently and will be accorded priority in publication. Letters to the editors will not be refereed, but will be published at the discretion of the Editors-in-Chief. If accepted, they will also be given priority. All papers accepted are subject to editorial amendment if necessary.

Presentation of manuscripts

Papers must be written in English. Because of the particular importance for analytical methods to be correctly reproducible great care should be taken to ensure that the style and quality is clear and unambiguous. Authors for whom English is a foreign language are recommended to have the paper thoroughly checked and corrected before submission. After the title of the paper and the authors' names the following should be given: (i) the establishment where the work was done, (ii) a summary of the essential contents of the paper, (iii) an indication of the principal author for correspondence. Where possible, papers should follow the pattern: Introduction, Experimental, Results and Discussion, References, or such of these sections as apply.

The presentation of tables, graphs and formulae should be kept to an absolute minimum and where possible the results from a series of investigations should be in a table form or as a graph. The same data should not be presented in both tables and figures or given in the Discussion as well as the Experimental section.

Tables and Figures

Tables should be so constructed as to be intelligible without reference to the text, every table and column being provided with a heading. Units of measure must always be clearly indicated. Unless it is essential to the argument, tables should not list the results of individual experiments, but should summarize results by an accepted method of expression (e.g. standard deviation). The same information should not be produced in both tables and figures. Footnotes to tables should be indicated by superscript letters. Figures should be provided as carefully prepared line drawings about twice the final size on plain white drawing paper, suitable for direct photographic reproduction. The original line drawings should be supplied with one of the copies of the manuscript. Each figure should be clearly marked on the back with the names of the authors and the figure number. Figure captions should be typed on a separate sheet.
Straight-line calibration graphs are not generally permitted: the necessary information can be included in the text (e.g. in the form of an equation).
More information on the preparation of your illustrations can be found at http://www.elsevier.com/locate/authorartwork.

Nomenclature

All references should conform as closely as possible to the rules established by IUPAC.

References

In the text refer to the subject or to the author's name (without initial), followed by the reference number in square brackets; the full references should be given in a list at the end of the paper in the following form:

[1] J.B. Austin and R.H.H. Pierce, J. Chem. Soc., 57 (1955) 661.

[2] S.T. Yoffe and A.N. Nesmeyanov, Handbook of Magnesium-Organic Compounds, 2nd edn., Vol. 3, Pergamon Press, Oxford, 1956, p. 214.

[3] A.J. Howard, Electron spin resonance spectroscopy, in T.P. Salthouse (Ed.), Structure Elucidation through Applied Spectroscopic Methods, Reidel, Dordrecht, 1986, pp. 229-253.

[4] A.B. Smith, The Effect of Radiation on Strength of Metals, A.E.R.E., M/R6329, 1962.

[5] N. Feldstein, U.S. Patent 3,574,644, 1971.

Journal-name abbreviations should be those adopted by the Chemical Abstracts Service (Bigliographic Guide for Editors and Authors, The Americal Chemical Society, Washington, DC, 1974). If the correct abbreviation is not known, the title should be given in full.

Articles on Disk

Authors are encouraged to submit final and accepted manuscripts on disk. Two copies of the printout should always be included. Disks must be clearly marked with at least the following: Operating system, disk format (DS/DD), software package used, Authors' names, short title of the paper.

Proofs & Reprints

Proofs, together with transfer of copyright and reprint order forms are despatched direct from the printers to the principal author (as indicated on the paper when submitted) for his or her approval and correction. After careful checking and correction these proofs should be returned without delay to Talanta, Elsevier Science Ltd., Bay 15K, Shannon Industrial Estate, Shannon, Co. Clare, Ireland. Fax: +353 61 472144.

Authors are kindly requested when proof reading to correct only those errors introduced by the printer. Modification to the text at proof stage will necessarily cause a delay in publication and incurs additional costs which may have to be charged to the authors or their institutions.

The publisher reserves the right to publish the paper without waiting for corrected proofs to be returned by the author, if waiting would cause undue delay.

Copyright: Authors are requested to read the note on copyright published inside the covers of each issue. Publication of paper may have to be delayed until a signed transfer of copyright agreement has been received. Authors are recommended to send the agreement at the same time as the proofs are returned.

Reprints: 25 free reprints will be provided to the principal author. Authors should indicate the number of additional paid reprints required when returning their proofs.

Author enquiries
For further information please visit the Author Gateway from Elsevier Science (http://authors.elsevier.com/journal/talanta) for the facility to track accepted articles and set up e-mail alerts to inform you when an article's status has changed. The Author Gateway also provides detailed artwork guidelines, copyright information, frequently asked questions and more.

Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided when an article is accepted for publication.